text: Acceleron Pharma $XLRN Receives “Hold” Rating from Cann https://t.co/RRqROCXmYX
time: Wed May 02 19:53:55 +0000 2018
text: Cann Reiterates “Hold” Rating for Acceleron Pharma $XLRN https://t.co/3o1oyn88wz
time: Wed May 02 19:50:23 +0000 2018
text: $FLXN $XLRN 2 Attractive Biotech Stocks To Buy Now https://t.co/TVvrfkRJsM
time: Wed May 02 19:11:25 +0000 2018
text: $XLRN 
2 Attractive Biotech Stocks To Buy Now $FLXN
https://t.co/8B6OjmNZZr
time: Wed May 02 18:43:31 +0000 2018
text: RT @Biotech2050: My fantasy biotech dream:
$CELG $GILD merge at equal levels 50:50
Then they buy $TGTX $ZIOP $KPTI $HALO $XLRN $SGMO 

Can…
time: Wed May 02 16:46:30 +0000 2018
text: Covered Call Alert: ACCELERON PHARMA INC. COMMON S $XLRN returning up to 32.49% through 17-Aug-2018 https://t.co/pda6yhYdWp https://t.co/lJVfzQzDp1
time: Wed May 02 15:44:31 +0000 2018
text: #FLXN short term price target $32, long term price target $45. Advice: Strong Buy
2 Attractive Biotech Stocks To Buy Now https://t.co/zy4Q8eY3ZT $FLXN, $XLRN
time: Wed May 02 15:38:44 +0000 2018
text: $HCW @HCWco has 6 New Research Reports in #Healthcare and 1 New Research Report in #CleanTechnology - visit https://t.co/68oSS2SQJl to see our Research Universe and Sign Up for our Research Distribution List $CCXI $XLRN $BOLD $AUPH $OXB.L $RIGL $RVLT
time: Wed May 02 14:49:07 +0000 2018
text: RT @Biotech2050: My fantasy biotech dream:
$CELG $GILD merge at equal levels 50:50
Then they buy $TGTX $ZIOP $KPTI $HALO $XLRN $SGMO 

Can…
time: Wed May 02 14:39:48 +0000 2018
text: My fantasy biotech dream:
$CELG $GILD merge at equal levels 50:50
Then they buy $TGTX $ZIOP $KPTI $HALO $XLRN $SGMO 

Can you just imagine the pipeline that could emerge! 
@Celgene @GileadSciences
time: Wed May 02 14:18:12 +0000 2018
text: Save the dates. We’re participating in 2 #healthcare investor conferences in May. Details here: https://t.co/jUYGLoIwko $XLRN
time: Wed May 02 11:03:58 +0000 2018
text: $celg $xlrn Biotech Forum: Tomorrow's Option Play https://t.co/fJJ9MbmfSW
time: Tue May 01 20:13:37 +0000 2018
text: RT @WallStJesus: TODAY'S UNUSUAL CALL FLOW &gt;&gt; $TER $AVP $SEAS $XLRN $MPC $CRTO $OZM $RDN
time: Tue May 01 18:47:16 +0000 2018
text: TODAY'S UNUSUAL CALL FLOW &gt;&gt; $TER $AVP $SEAS $XLRN $MPC $CRTO $OZM $RDN
time: Tue May 01 18:37:59 +0000 2018
text: Acceleron Pharma $XLRN Given Hold Rating at Cann https://t.co/3V9FDX53g5
time: Tue May 01 17:14:32 +0000 2018
text: FIRST TAKE NOTE on $XLRN by Edward White - Acceleron Receives Fast Track Designation for ACE-083 in FSHD - visit https://t.co/68oSS2SQJl to see our Research Universe and Sign Up for our Research Distribution List

$HCW @HCWco
time: Tue May 01 16:51:20 +0000 2018
text: RT @AcceleronPharma: Today we announced that ACE-083, our lead neuromuscular candidate to treat FSHD, received Fast Track designation from…
time: Tue May 01 15:41:56 +0000 2018
text: Analysts’ Opinions Are Mixed on These Healthcare Stocks: Acceleron Pharma (NASDAQ: XLRN) and Incyte Corp (NASDAQ: INCY) $XLRN https://t.co/h03d4aZnoQ
time: Tue May 01 15:15:47 +0000 2018
text: Acceleron's ACE-083 Fast Track'd for type of muscular dystrophy https://t.co/EzFiaE4V24 $XLRN
time: Tue May 01 14:56:10 +0000 2018
text: H.C. Wainwright Reaffirms Their Buy Rating on Acceleron Pharma $XLRN https://t.co/vaEBRw2DiY
time: Tue May 01 14:29:52 +0000 2018
text: SMALL EARLY BULL FLOW INTO SELECTIVE RED &gt;&gt; $MSFT $XLRN $ABBV $F $INTC
time: Tue May 01 14:02:52 +0000 2018
text: RT @tgtxdough: LR $CELG Bottom Line: The two phase III read-outs for XLRN’s luspatercept are integral to Celgene’s (CELG, OP) mid-2018 cata…
time: Tue May 01 13:11:08 +0000 2018
text: LR $CELG Bottom Line: The two phase III read-outs for XLRN’s luspatercept are integral to Celgene’s (CELG, OP) mid-2018 catalyst path, and we believe these trials offer 3-4% upside based on the implied product revenue of its collaborator Acceleron’s $XLRN
time: Tue May 01 13:06:00 +0000 2018
text: $XLRN: Acceleron Pharma: FDA has granted Fast Track designation to ACE-083for the treatment of patients with... https://t.co/fQJwnO5829
time: Tue May 01 13:02:05 +0000 2018
text: $XLRN Acceleron Receives FDA Fast Track Designation https://t.co/000syrrSE0 https://t.co/000syrrSE0
time: Tue May 01 12:00:55 +0000 2018
text: RT @AcceleronPharma: Today we announced that ACE-083, our lead neuromuscular candidate to treat FSHD, received Fast Track designation from…
time: Tue May 01 11:08:05 +0000 2018
text: RT @odibro: $XLRN Receives FDA Fast Track Designation for ACE-083 in Facioscapulohumeral Muscular Dystrophy (FSHD)
time: Tue May 01 11:05:27 +0000 2018
text: Today we announced that ACE-083, our lead neuromuscular candidate to treat FSHD, received Fast Track designation from FDA. Read more here: https://t.co/I4ipX2UQfN #FSHD $XLRN
time: Tue May 01 11:03:54 +0000 2018
text: RT @odibro: $XLRN Receives FDA Fast Track Designation for ACE-083 in Facioscapulohumeral Muscular Dystrophy (FSHD)
time: Tue May 01 11:03:52 +0000 2018
text: RT @trading_mz: *ACCELERON GETS FDA FAST TRACK FOR ACE-083 IN FSHD $XLRN
time: Tue May 01 11:03:42 +0000 2018
text: $XLRN Receives FDA Fast Track Designation for ACE-083 in Facioscapulohumeral Muscular Dystrophy (FSHD)
time: Tue May 01 11:03:07 +0000 2018
text: *ACCELERON GETS FDA FAST TRACK FOR ACE-083 IN FSHD $XLRN
time: Tue May 01 11:02:19 +0000 2018
text: RT @NickVRamos: $CELG regardless analyst put out opinions everyday. Take it or leave it. Shouldn't be trading short term on biotech. This i…
time: Tue May 01 05:05:29 +0000 2018
text: Added to $XLRN
time: Tue May 01 01:21:46 +0000 2018
